Leadership Team
Our executive team features a diverse group of experienced healthcare and technology professionals who help guide Glooko to drive superior innovation and commercial results
Board of Directors
Our Board of Directors is made up of industry executives and founders who support, advise and enable Glooko to be the leader in data management and remote patient monitoring for diabetes and other chronic conditions
Alfonso (Chito) Zulueta
Board Director of CTS Corp., Syneos Health, Inc., CALIDI BioTherapeutics;
Retired-President, International at Eli Lilly and Company /
Board Member
Medical Advisory Board
Mark Clements, M.D., Ph.D.
Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children’s Mercy Kansas City